Avient Corporation
NYSE:AVNTChemicals - Specialty
+$0.04 today
- Market cap
- $4.07B
- Beta
- 1.30
- P/E (TTM)
- 21.4
- EPS (TTM)
- $1.72
- Dividend yield
- 2.97%
Volume 0.55M
Average 0.74M
AVNT Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Avient CorporationNYSE: AVNT
Revenue · Q3 FY2026 · quarter ended Sep 2026
Revenue growth accelerates
Q3 FY2026 revenue of $891.2M rose 10.5% year over year, ahead of the +5.2% change in trailing-twelve-month revenue. Sequentially, it fell 2.8% from the prior quarter. Over 3 fiscal years it compounded at -1.4% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 5 analysts of $3.48B (+6.7%) for the fiscal year ending Dec 2026, a step up from the +0.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $891.2M-2.8% QoQ
- Last fiscal yearDec 2025
- $3.26B+0.6% YoY
- LTMSep 2026
- $3.42B+5.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +10.5% | +7.9% | -2.6 pp |
| 1 year | +0.6% | +6.7% | +6.1 pp |
| 3-year CAGR | -1.4% | +4.5% | +5.9 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 3.26B USD
- Year-over-year change
- +0.6%
- 4-year CAGR
- -0.4%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.26B | +0.6% |
| FY2024 | 2024-12-31 | 3.24B | +3.1% |
| FY2023 | 2023-12-31 | 3.14B | -7.5% |
| FY2022 | 2022-12-31 | 3.4B | +2.5% |
| FY2021 | 2021-12-31 | 3.32B | — |
Revenue vs competitors
How AVNT compares with its peers on the latest reported figures
- AVNT's LTM Sep 2026 revenue of $3.42B is the 5th highest of the 11 companies compared; the peer median is $2.42B.
- Its year-over-year change of +5.2% is the 7th highest of 11, against a peer median of +8.6%.
- Over three fiscal years its annual growth of -1.4% compares with a peer median of -2.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $6.7B | +0.6% | -10.2% | |
| LTM Jun 2026 | $4.27B | +19.2% | -5.9% | |
| LTM Jun 2026 | $3.63B | -4.7% | -4.9% | |
| LTM Aug 2026 | $3.55B | +1.5% | -2.5% | |
| LTM Sep 2026 | $3.42B | +5.2% | -1.4% | |
| LTM Sep 2026 | $3B | +18.7% | -3.1% | |
| LTM Jun 2026 | $1.84B | -1.4% | -8.6% | |
| LTM Jun 2026 | $1.7B | +8.1% | +3.9% | |
| LTM Sep 2026 | $1.14B | +9.0% | +5.0% | |
| LTM Jun 2026 | $757.07M | +24.2% | +21.9% | |
| LTM Aug 2026 | $687.99M | +11.0% | +8.6% | |
| Peer median (excluding AVNT) | $2.42B | +8.6% | -2.8% | |
Competitors are the stored peer set for AVNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.32B | 3.4B | 3.14B | 3.24B | 3.26B |
| Cost of Revenue | 2.37B | 2.51B | 2.24B | 2.18B | 2.2B |
| Gross Profit | 943.8M | 882.7M | 902.7M | 1.06B | 1.06B |
| Gross Margin | 28.5% | 26.0% | 28.7% | 32.6% | 32.5% |
| Research & Development | 0 | 84.9M | 90.3M | 98.7M | 0 |
| Selling, General & Admin | 664.1M | 639.4M | 590.9M | 727.4M | 695.4M |
| Operating Expenses | 664.1M | 639.4M | 681.2M | 727.4M | 854.7M |
| Depreciation & Amortization | 145.9M | 163.1M | 188.8M | 179.7M | 185.9M |
| EBITDA | 424.6M | 346.7M | 391.4M | 510.1M | 548.7M |
| EBITDA Margin | 12.8% | 10.2% | 12.5% | 15.7% | 16.8% |
| Operating Income | 279.7M | 243.3M | 221.5M | 329.3M | 203.5M |
| Operating Margin | 8.4% | 7.2% | 7.0% | 10.2% | 6.2% |
| Interest Income | 17.5M | 34M | 0 | 0 | 0 |
| Interest Expense | 105.1M | 182.3M | 115.3M | 105.6M | 98.6M |
| Other Income / Expenses | (76.2M) | (179.5M) | (134.2M) | (104.5M) | (91.8M) |
| Income Before Tax | 203.5M | 63.8M | 87.3M | 224.8M | 111.7M |
| Pre-Tax Margin | 6.1% | 1.9% | 2.8% | 6.9% | 3.4% |
| Income Tax Expense | 51.9M | (19.3M) | 11M | 54.1M | 28.1M |
| Net Income | 230.8M | 153M | 75.7M | 169.5M | 81.9M |
| Net Margin | 7.0% | 4.5% | 2.4% | 5.2% | 2.5% |
| EPS (Basic) | 2.53 | 7.71 | 0.83 | 1.86 | 0.90 |
| EPS (Diluted) | 2.51 | 1.66 | 0.82 | 1.84 | 0.89 |
| Weighted Avg Shares | 91.4M | 91.2M | 91.1M | 91.3M | 91.5M |
| Weighted Avg Shares (Diluted) | 92.1M | 92.2M | 91.8M | 92M | 91.8M |
Avient Corporation
NYSE:AVNT
Intrinsic Alpha fair value
Locked
Current Price
$44.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.